Fundz

Incyte Appoints Steven Stein as Chief Medical Officer and Pablo Cagnoni as President

PUBLIC · INCYMar 25, 2026

Position

Executive Vice President

Company

Incyte Corporation

Steven Stein, M.D.
WilmingtonBiotechnologyTherapeuticsPharmaceuticalBiopharma

Description

Incyte has announced several executive leadership appointments to enhance its strategic focus and long-term growth. Notably, Steven Stein has been appointed Chief Medical Officer, and Pablo Cagnoni has been appointed President.

Quick answer

Incyte Appoints Steven Stein as Chief Medical Officer and Pablo Cagnoni as President (March 25, 2026). Incyte Corporation is based in Wilmington, Delaware, United States.

What did Incyte Corporation announce on March 25, 2026?
Incyte has announced several executive leadership appointments to enhance its strategic focus and long-term growth. Notably, Steven Stein has been appointed Chief Medical Officer, and Pablo Cagnoni has been appointed President.
What does Incyte Corporation do?
Incyte is a global biopharmaceutical company focused on advancing innovative medicines through deep scientific expertise and a patient-centered approach.
Where is Incyte Corporation based?
Incyte Corporation is based in Wilmington, Delaware, United States.
Which similar companies made leadership changes around the same time?
Aurinia Pharma (March 23, 2026), Aquestive Therapeutics, Inc. (March 20, 2026), Atossa Therapeutics (March 19, 2026) and Vanda Pharmaceuticals (April 2, 2026) also announced leadership changes within 45 days of Incyte Corporation.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Pharmaceutical

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Incyte Corporation, and when

A new leader at Incyte Corporation brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Incyte Corporation raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Incyte Corporation, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Incyte Corporation. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Incyte Corporation

Location

1801 Augustine CUT-OFF

Wilmington, Delaware, United States

About

Incyte is a global biopharmaceutical company focused on advancing innovative medicines through deep scientific expertise and a patient-centered approach. The company has built an established portfolio of first-in-class medicines and a broad pipeline of next-generation therapies across its core franchises of Hematology, Oncology, and Inflammation & Autoimmunity.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Incyte Corporation changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Christiana
Likely contact at this company
••••••••@••••••••

See Christiana's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Incyte Corporation's next move

Learn about Strategic plan

Incyte Corporation changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.